GLP Watchdog

Midi Health vs Noom

Neither Midi Health nor Noom has an FDA warning letter on record. Midi Health lists its visit fee, and the medication is billed separately, so it has no all-in monthly price to set against another seller's. Noom starts at $179 a month for compounded semaglutide injection.

To see where both sit among the other sellers, read our best weight-loss injection providers board.

By Ruth Calder · Enforcement Editor
Editorially reviewed. Not medical advice · How we verify contentLast reviewed

The record

Midi Health / Noom

Midi Health logo

Midi Health

4.9/10

Noom logo

Noom

5.8/10

FDA warning letters
None on record
None on record
Pharmacy
  • Precision Compounding Pharmacytype not stated
None named in our record
Lowest standing price
No GLP-1 price published
$179/moCompounded semaglutide injection
States
All 50 states
No state list published
Checked
Prices captured Record checked September 2026
Prices captured Record checked October 2026
Visit Midi Health
Visit Noom

Neither Midi Health nor Noom pays us. Links to them earn nothing. Scores: Midi Health 4.9, Noom 5.8. How we are paid

What the record shows

  1. 01

    Neither Midi Health nor Noom has an FDA warning letter on record.

  2. 02

    Midi Health names Precision Compounding Pharmacy. Noom names no compounding pharmacy in our record.

  3. 03

    Midi Health lists its visit fee, and the medication is billed separately, so it has no all-in monthly price to set against another seller's. Noom starts at $179 a month for compounded semaglutide injection.

  4. 04

    Only Noom lists a price for compounded semaglutide injection and brand-name tirzepatide pen.

  5. 05

    Midi Health lists all 50 states. Noom publishes no state list.

  6. 06

    Midi Health does not state its cancellation terms; Noom states you can cancel at any time.

Prices and terms, product by product

A price is set against the other side only for the same product, and only when both are standing monthly or 4-week rates. Those pairs are compared by yearly cost.

Midi Health

Noom

Compounded semaglutide injection
Not sold or not priced

$179/mo

$2,148 a year

Brand-name tirzepatide pen
Not sold or not priced

$349/mo

$4,188 a year

Price includes
Not stated
Clinician visits, coaching
Cancel any time
Not stated
Yes, stated
Refunds
Payments are non-refundable; an order may be canceled before shipment at Midi's discretion
Refunds only before a prescription is written; renewal charges are not refunded

Read off each seller’s own pages. Midi Health: September 28, 2026. Noom: October 30, 2026. Every plan and dose we hold is on the full review.

The case for each

The case for Midi Health

4.9/10
  • Names its compounding pharmacy
  • Publishes no GLP-1 price
Visit Midi Health

The case for Noom

5.8/10
  • Sells compounded semaglutide injection and brand-name tirzepatide pen, which Midi Health does not price
  • States you can cancel at any time
  • Names no compounding pharmacy
  • Publishes no state list
Visit Noom

Scores

Midi Health 4.9 · Noom 5.8 out of 10. Six weighted parts.

Value25%

3.0A
vs
B
0.9

Effectiveness25%

5.0A
vs
B
10.0

User Experience15%

2.5A
vs
B
8.0

Trust & Safety15%

6.5A
vs
B
6.5

Accessibility10%

10.0A
vs
B
5.0

Support10%

5.0A
vs
B
4.0

The score is the same formula for every seller. Payment does not enter it. Method

Midi Health vs Noom: questions

Neither Midi Health nor Noom has an FDA warning letter on record. Letters are matched to a seller by company, domain and address, never by a similar name.
Midi Health names Precision Compounding Pharmacy. Noom names no compounding pharmacy in our record.
Midi Health does not state its cancellation terms. Noom states you can cancel at any time; refunds: refunds only before a prescription is written; renewal charges are not refunded.
Neither Midi Health nor Noom pays us. Links to them earn nothing. Scores: Midi Health 4.9, Noom 5.8.

Other sellers we are paid by

Affiliate partners outside this pair. Each has its own record and review, scored the same way.

Sellers closest to these two

Matched on molecule, form and price. Every pair we list · The register

Brand names on this page are registered marks. Novo Nordisk holds Wegovy®, Ozempic® and Rybelsus®; Eli Lilly holds Zepbound®, Mounjaro® and Foundayo®. Neither company has any tie to GLP Watchdog. Trademarks